Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Dog receives groundbreaking cancer treatment
Ralph was presented to the University of Edinburgh's Hospital for Small Animals suffering from repeated nosebleeds.

Technique had previously only been available in human medicine.

A five-year-old dog from Lanark, Scotland, has been successfully treated for an aggressive form of cancer thanks to a state-of-the-art treatment used in the UK for the first time.

Gordon setter Ralph is said to have responded well to high-tech radiation therapy for a tumour in his nose. Vets used a specialised technique in which a radiation beam is shaped to the exact shape of the tumour.

Ralph was presented to the University of Edinburgh's Hospital for Small Animals suffering from repeated nosebleeds. Tests confirmed a growth in his nose that was affecting his breathing.

Ralph received a technique called Intensity Modulated Radiation Therapy (IMRT),  delivered by a linear accelerator machine called Vital Beam. Until now, IMRT has only been available in human medicine.

IMRT works by delivering precise radiation to tumours while minimising risk to the surrounding healthy tissue. In Ralph's case, the technique only had a mild effect on the surrounding eye and brain tissue, and side effects were limited when compared with standard treatment.

Since undergoing the therapy, Ralph's nosebleeds have stopped, and he is back home enjoying being with his family. The team says that while his tumour may return, the treatment has ensured the best possible quality of life.

Magdalena Parys, a radiation oncology specialist vet from the Royal (Dick) School of Veterinary Studies, said: “We are fortunate to have cutting-edge technology available for our patients. This advanced technology allows us to spare much more of normal healthy tissue and gives us the ability to increase radiation doses to tumours.

“Our primary goal is to fight cancer, but at the same time, improve or maintain a good quality of life. We are delighted with Ralph’s progress and hope he will enjoy a good quality of life for a long time with his loving owners.”

Jenna Forbes, Ralph’s owner said: “The Dick Vet team were reassuring at a scary time and had such determination to fight for Ralph. We knew he was getting the best care possible, and after his treatments, we always brought home a dog that had been well cared for.

"His condition is significantly better now. We have such confidence in everyone at the Dick Vet, they are a dream team.”

Image (C) University of Edinburgh.

Become a member or log in to add this story to your CPD history

Voting opens for BEVA Council

News Story 1
 Eligible members of BEVA will be able to vote for their Council team until Monday, 17 August 2026. Members will have received an election email on 17 July.

There are five candidates standing for four available places on Council. They are:

  • Alexandre Triguino
  • Angela Jones
  • Beth Bryant
  • Holly Rees
  • Hugh Somerville
Full profiles for each candidate can be found on the BEVA website

Click here for more...
News Shorts
Milk recalled over presence of veterinary medicines

Graham's Family Dairy has issued a recall for its semi-skimmed milk due to the presence of veterinary medicines in the product.

In a risk statement, the Food Standards Agency said the presence of the medicines, including penicillin, make the milk unsafe to consume and 'may be a possible health risk for anyone with an allergy to antibiotics'.

Customers who bought the product are advised to return it to the store of purchase for a full refund.